AFP and hepatocellular carcinoma: The goal of the new extended criteria for HCC patients would be to enable the maximal enrollment of candidates while securing a 5-year recurrence rate below 10% (with a 95% upper confidence limit) by examining various combinations of tumor numbers and AFP and/or PIVKA-II values, maintaining the maximal tumor diameter at 5 cm.